General
Preferred name
MELITRACEN
Synonyms
Trausabun ()
Thymeol hydrochloride ()
Melixeran ()
MELITRACEN HYDROCHLORIDE ()
Melitracen (hydrochloride) ()
Adelax ()
U-24,973A ()
U-24973A ()
U 24973A ()
U 24,973A ()
Melitracen hcl ()
NSC-78229 ()
P&D ID
PD014108
CAS
10563-70-9
5118-29-6
Tags
available
drug candidate
drug
Drug Status
experimental
investigational
approved
Max Phase
Phase 3
Drug indication
Antidepressant
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Melitracen hydrochloride is a potential dopamine D1/2 receptor antagonist. It has been used in combination with flupentixol in depression therapy. (BOC Sciences Bioactive Compounds)
Compound Sets
11
DrugBank
DrugCentral
DrugCentral Approved Drugs
DrugMatrix
MedChem Express Bioactive Compound Library
NPC Screening Collection
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
External IDs
38
Properties
(calculated by RDKit )
Molecular Weight
291.2
Hydrogen Bond Acceptors
1
Hydrogen Bond Donors
0
Rotatable Bonds
3
Ring Count
3
Aromatic Ring Count
2
cLogP
4.71
TPSA
3.24
Fraction CSP3
0.33
Chiral centers
0.0
Largest ring
6.0
QED
0.79
Structural alerts
1
styrene_B(8)
c:1:c:c-2:c(:c:c:1)-[#6](-c:3:c(-[$([#16;X2]),$([#6;X4])]-2):c:c:[c;!H0,$(c-[#17]),$(c-[#6;X4])](:c:3))=[#6]-[#6]
PAINS Family C
Custom attributes
(extracted from source data)
Pathway
GPCR/G protein
Neuronal Signaling
Target
D1
D2
5-HT Receptor
MOA
Dopamine Receptor
Source data